Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CUBRC, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2011-09-27 to 2022-04-05
Current total value of award: $33430604.09
Description: NOVEL TETRACYCLINE COUNTERMEASURE FOR RESPIRATORY DISEASE CAUSED BY BIOTHREAT AND ANTIBIOTIC-RESISTANT PUBLIC HEALTH PATHOGENS